HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED – Trademark Portfolio

Entity Type: 03

HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED holds 1 U.S. trademark filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 1 filings in this category. Currently, 1 trademark is registered. Notable registered marks include SABOOS. The owner is based in HONG KONG.

ROOM 602, 6TH FLOOR, QIRU COMMERCIAL BUILDING, 2C ARGYLE STREET, MONG KOK, KOWLOON

HONG KONG 999077 , HK

1 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

SABOOS
SABOOS
Registered 2025

Trademark Classifications

HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED's trademark portfolio spans 1 Nice Classification class, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (1 filing)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

Frequently Asked Questions

How many trademarks does HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED have?

HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED has 1 U.S. trademark filed with the USPTO. Of these, 1 registered.

What trademark classes does HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED file in?

HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED files trademarks across 1 Nice Classification class. The most active classes are Class 5 (Pharmaceuticals). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED's most well-known trademarks?

HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED's registered trademark portfolio includes well-known marks such as SABOOS. These are among 1 currently registered trademark in the portfolio.

What is HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED's trademark registration success rate?

HONG KONG SABOOS BIOTECHNOLOGY CO .,LIMITED has a 100% trademark registration rate, with 1 out of 1 resolved applications resulting in successful registration. Currently, 0 applications are pending review.